The potential for development of clinically relevant microbial resistance to rifaximin-α: a narrative review.
Article in Clinical Microbiology Reviews (November 2023)
The most recent citing publications are shown below. View all 17 publications that cite this research output on Dimensions.
Rifaximin: unique selective antibiotic for the treatment of gastrointestinal diseases
Article in Meditsinskiy sovet = Medical Council (May 2021)
Rifaximin improves survival in cirrhotic patients with refractory ascites: A real-world study
Article in World Journal of Gastroenterology (January 2020)